I clicked the link from the insider ownership site to the Institutional investors. As we have discussed in the past, the information was remarkable. There are many investors on this board, including myself, that have more shares than any of the small three institutional investors that hold shares in CYDY (or all three combined).

To be frank, this still concerns me. I have worked with many venture and private equity firms, and they tend to share an overwhelming desire to source under-the-radar opportunities to make some real money. The risk/reward on CYDY is extraordinary and I can't understand why pharma focused institutional investors haven't jumped in.

NP and MM have not targeted these investors, nor are they experienced in raising funds from these type of investors, but some analyst in one or more of these firms must have come across CYDY. That is the job of a lot of the junior people in the firm -- to find the diamonds in the rough.

When we finally get these institutional investors jumping in, then we will finally get the buying power to start moving the PPS up. Retail investors are not going to lift the price by themselves.